CN105943633A - Herba cistanches health care product and application thereof - Google Patents
Herba cistanches health care product and application thereof Download PDFInfo
- Publication number
- CN105943633A CN105943633A CN201610304500.3A CN201610304500A CN105943633A CN 105943633 A CN105943633 A CN 105943633A CN 201610304500 A CN201610304500 A CN 201610304500A CN 105943633 A CN105943633 A CN 105943633A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba cistanches
- herba
- health product
- health care
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Abstract
The invention belongs to the field of health care products, and discloses a herba cistanches health care product. An active ingredient of the herba cistanches health care product is prepared from the following raw materials in parts by weight: 2 parts of herba cistanches, 50 parts of lysimachia hypericoides herb, 60 parts of conyza blinii herb, 55 parts of herb of common maidenhair spleenwort, 60 parts of herba geranii, 40 parts of gymnema latifolium stems and leaves and 50 parts of cyrtomium caryotideum herb. The invention also discloses an effect of the herba cistanches health care product on preventing and treating arthritis.
Description
Technical field
The present invention relates to Chinese medicine health care product technical field, be specifically related to the preparation method of a kind of Herba Cistanches health product and answer
With.
Background technology
Arthritis refer to generation in human synovial and the inflammatory diseases of surrounding tissue thereof, tens of kinds can be divided into.The pass of China
The scorching patient of joint has more than 100,000,000, and number is being continuously increased.Clinical manifestation be joint red, swollen, hot, bitterly, dysfunction and joint
Deformity, severe patient causes joint deformity, affects patients ' life quality.Up to now, people are look for one and make simple, clothes
With preventing and treating arthritic medicine easily.
Summary of the invention
Goal of the invention: in order to solve the problems referred to above, it is an object of the invention to provide the preparation of a kind of Herba Cistanches health product
Method and application.
Technical scheme: it is an object of the invention to by following scheme realization:
A kind of Herba Cistanches health product, its contained active component is prepared from by following raw materials in part by weight proportioning: Herba Cistanches 2
Part, Herba Lysimachiae hypercodis 50 parts, conyza blinii 60 parts, Herba asplenii trichomanis 55 parts, geranium 60 parts, wide leaf Largeleaf Gymnema 40 parts, ratchet
Rhizoma Osmundae 50 parts.
Described Herba Cistanches health product, preparation method step is: take the above-mentioned merging of other medical materials, boiling in addition to Herba Cistanches
Twice, collecting decoction, when being concentrated into 65 DEG C, relative density is 1.10-1.20, adds ethanol, stirring, makes alcohol content by volume hundred
Proportion by subtraction calculates and reaches 65-85%, stands, and filters, and during filtrate reduced in volume to 65 DEG C, relative density is 1.20-1.30 and reclaims second
Alcohol, is spray-dried concentrated solution, and gained granular powder is broken into dry extract, adds Herba Cistanches and adjuvant, makes required preparation.
Described Herba Cistanches health product, in preparation method, decocting condition is: amount of water is 8-12 times of medical material weight for the first time
Amount, decocts 1-2h, and amount of water is the 6-10 times amount of medical material weight for the second time, decocts 1-2h.
Described Herba Cistanches health product, in preparation method, spray drying condition is: inlet temperature is 90-110 DEG C, leaving air temp
For 60-90 DEG C, temperature of charge is 60-90 DEG C, and atomizing pressure is 0.2-0.5 MPa, and spray velocity is 1-10ml/s.
The application in preparing anti-curing arthritis health product of the described Herba Cistanches health product.
Above-mentioned Herba Cistanches (formal name used at school: Cistanche deserticola Ma), calls boundary rue, very little rue, Herba Cistanches, looks into dry announcement Asia
(Mongolian), belongs to endangered species.Tall and big draft, high 40-160 centimetre, mostly lower raw.The month at florescence 5-6, really the phase 6-8 month.Main product in
Xinjiang, Alashan Area, inner Mongolia Autonomous Region alliance, also there is distribution in Gansu, Ningxia.Herba Cistanches is a kind of to colonize in posting of desert trees sacsaoul root
Raw plant, draws nutrient and moisture content from sacsaoul host.Have the good reputation of " desert Radix Ginseng ", there is high medical value, be
The rare Chinese medicine of Chinese tradition.Herba Cistanches the most just by Western Regions various countries as the treasure of Shang Gong imperial court, be also to mend in the successive dynasties
One of tonification medicine that in kidney and enhancing body class prescription, usage frequency is the highest.
Herba Lysimachiae hypercodis, Classification system Lysimachia hypericoides Hemsl., for Primulaceae, gathers summer
Storage of gathering dries or using fresh herb, heat-clearing and toxic substances removing, cooling blood for hemostasis.For ulcerative carbuncle toxic swelling, gastrointestinal hemorrhage, metrorrhagia.The present invention is with herb
It is used as medicine.
Conyza blinii is the false fluffy platymiscium little Herba Acroptili repentis Conyza blinii Levl. of Compositae, with all herbal medicine.Autumn adopts
Receive, decontamination, using fresh herb or dry in the shade.Heat clearing and inflammation relieving, eliminating fire and detoxication.For acute icterohepatitis, toothache, chronic tracheitis, mouth
Chamber is scorching, pharyngolaryngitis, tonsillitis, nephritis, malaria；Eye conjunctivitis, otitis media, skin infection, eczema, traumatic hemorrhage are controlled in external.
Herba asplenii trichomanis is fern Aspleniaceae spleen wort Asplenium trchomanes L. Asplenium trichomanes L., with
All herbal medicine, heat-clearing and toxic substances removing, regulating menstruation, hemostasis, restrain leukorrhagia stopping.For infantile hyperpyrexia, leucorrhea, menoxenia；Burn and scald is controlled in external,
Traumatic hemorrhage, furuncle swelling toxin, venom.
Geranium is the aerial parts of Niu Er Seedling section plant cattle Seedling ErodiumstephnaianumWilld., summer and autumn
Gather.Remove rheumatism.For rheumatic arthralgia.
Wide leaf Largeleaf Gymnema, Latin entitled Cymnema latifolium Wall.ex Wight, trailing plants section Gymnema
Plant drying stem and leaf.Hair external hemostasis, convergence.Sustainability external application forged by fire.The present invention is used as medicine with Herb.
Cyrtomium caryotideumPresl is Dryopteridaceae Cyrtomium plant, latin name: Cyrtomium caryotideum (Wall.ex
Hook.et Grev.) Presl, heat-clearing and toxic substances removing, promoting blood circulation to remove blood stasis, diuretic.For scrofula, furunculosis furuncle and phyma, flu, metrorrhagia, traumatic injury damages
Wound, edema.The present invention is with all herbal medicine.Remaining is pharmacopeia kind.
Beneficial effect: Herba Lysimachiae hypercodis of the present invention, conyza blinii heat-clearing and toxic substances removing, cooling blood for hemostasis is monarch drug, Herba asplenii trichomanis,
Geranium, wide leaf Largeleaf Gymnema, cyrtomium caryotideumPresl remove rheumatism are ministerial drug, and Herba Cistanches is adjuvant, full side mutually compatibility, dispel wind
Wet, heat-clearing and toxic substances removing, treatment of arthritis effect is obvious.
Detailed description of the invention
Form by the following examples, is described in further detail the foregoing of the present invention again, but should be by this
Being interpreted as that the scope of the above-mentioned theme of the present invention is only limitted to Examples below, all technology realized based on foregoing of the present invention are equal
Belong to the scope of the present invention.
Embodiment 1: take Herba Lysimachiae hypercodis 50g, conyza blinii 60g, Herba asplenii trichomanis 55g, geranium 60g, wide leaf spoon
Rattan 40g, cyrtomium caryotideumPresl 50g medical material mix, boiling twice, and add water 8 times amount into medical material weight for the first time, decocts 1.5h,
Add water 6 times amount into medical material weight for the second time, decocts 1h, collecting decoction, filters, and filtrate is concentrated into relative density 1.10 (65
DEG C), adding ethanol in proper amount and make alcohol content (volume fraction) reach 65%, stir, stand 24 hours, filter, filtrate recycling ethanol is the denseest
Be reduced to the extractum of relative density 1.10 (65 DEG C), spray-dried (condition be inlet temperature be 100 DEG C, leaving air temp is 80 DEG C,
Temperature of charge is 70 DEG C, and atomizing pressure is 0.2 MPa, and spray velocity is 5ml/s.), it is ground into dry extract, adds meat desert
Rong powder 2g, dextrin 50g, with appropriate 80% ethanol wet, soft material processed, cross 14 mesh sieves and pelletize, and 70 DEG C are dried, 60 mesh granulate,
Granule.
Embodiment 2: take Herba Lysimachiae hypercodis 50g, conyza blinii 60g, Herba asplenii trichomanis 55g, geranium 60g, wide leaf spoon
Rattan 40g, cyrtomium caryotideumPresl 50g medical material mix, boiling twice, the 10 times amount into medical material weight that add water, and decoct 2h, and second
Secondary 8 times amount added water as medical material weight, decoct 1h, collecting decoction, filter, and filtrate is concentrated into relative density 1.15 (65 DEG C), adds
Ethanol in proper amount makes alcohol content (volume fraction) reach 75%, stirs, stands 24 hours, filters, and filtrate recycling ethanol is also concentrated into phase
Extractum to density 1.25 (65 DEG C), spray-dried (condition be inlet temperature be 120 DEG C, leaving air temp is 90 DEG C, material temperature
Degree is 80 DEG C, and atomizing pressure is 0.3 MPa, and spray velocity is 7.5/s.), it is ground into dry extract 50g, adds Herba Cistanches powder
2g, starch 50g, mix homogeneously, with appropriate 80% ethanol wet, soft material processed, cross 30 mesh sieves and pelletize, be dried in 70～80 DEG C, use
60 mesh sieve granulate, tabletting, coating, subpackage, outer package, censorship is qualified, obtains finished product.
Embodiment 3: take Herba Lysimachiae hypercodis 50g, conyza blinii 60g, Herba asplenii trichomanis 55g, geranium 60g, wide leaf spoon
Rattan 40g, cyrtomium caryotideumPresl 50g medical material mix, boiling twice, and add water 10 times amount into medical material weight for the first time, decocts 1.5h,
Add water 8 times amount into medical material weight for the second time, decocts 1.5h, collecting decoction, filters, and filtrate is concentrated into relative density 1.15 (65
DEG C), adding ethanol in proper amount and make alcohol content (volume fraction) reach 75%, stir, stand 24 hours, filter, filtrate recycling ethanol is the denseest
Be reduced to the extractum of relative density 1.25 (65 DEG C), spray-dried (condition be inlet temperature be 120 DEG C, leaving air temp is 90 DEG C,
Temperature of charge is 90 DEG C, and atomizing pressure is 0.4 MPa, and spray velocity is 7.5/s.), it is ground into dry extract, crosses No. 6 sieves, add
Enter Herba Cistanches powder 2g, starch 50g, reinstall No. 1 capsule finished product.
Embodiment 4: the present invention treats the experimentation of rheumatic arthritis
The preparation of sample: prepare by above-mentioned granule embodiment method, mouse stomach, by Mice Body restatement, low dosage, in
Dosage and high dose are respectively 5g crude drug amount/kg, 10g crude drug amount/kg and 20g crude drug amount/kg.
Instrument and reagent: bath cabinet (upper Nereid grand experimental facilities company limited), the 8452A type ultraviolet spectrophotometer (U.S.
Hewlett-Packard)；TG328A type photoelectric analytical balance (Shanghai balance equipment factory).Glacial acetic acid (Shanghai reagent four factory, lot number:
090402) aspirin tablet, Nanjing Pharmaceutical Plant, lot number 20100216
Animal: Kunming mouse 210, female, body weight (20.1 ± 2.4) g, by Nanjing Medical University's Experimental Animal Center
There is provided (SYXK (Soviet Union) 2000-0053).
Analgesic activity (hot plate method) test: divide 5 groups at random by 50 mices, i.e. negative control group, positive controls, this
Bright large, medium and small dosage group, often group is 10；Next day gastric infusion, continuous 7d, the large, medium and small dosage of the present invention；Positive control
Group is to aspirin tablet, and dosage is 20g kg-1 d-1；Negative control group gavage 0.9% sodium chloride solution, volume is often
2ml, carries out analgesic activity (hot plate method) experiment after drug withdrawal 24h.
By water bath topped up with water, making the water surface contact hot plate, regulating thermostatic device makes water temperature control at 55 ± 0.5 DEG C, heating
Afterwards as thermostimulation, with stopwatch record mice from putting into hot plate to occurring that licking the sufficient time (s) (surveys 2 as the pain threshold of this Mus
Secondary, it is less than 60 seconds persons for qualified with meansigma methods), 1h after being administered the 3rd day, then survey every pain threshold.
Analgesic activity (writhing method) test: divide 5 groups at random by 50 mices, i.e. negative control group, positive controls, this
Bright large, medium and small dosage group, often group is 10；Next day gastric infusion, continuous 7d, the large, medium and small dosage of the present invention is respectively 40,
20,10g kg-1 d-1 (suitable crude drug)；Positive controls is to aspirin tablet, and dosage is 20g kg-1 d-1；Negative
Matched group gavage 0.9% sodium chloride solution, volume is every 2ml, carries out analgesic activity (writhing method) experiment after drug withdrawal 24h.
Within 3rd day, it is administered latter 1 hour, every Mus lumbar injection 0.6% glacial acetic acid 0.1ml/10g, after record injection algogen
In 10min, each Mus writhing number of times, compares group difference.
Table 1 present invention impact (x ± s) on mice analgesic activity
Compare with negative control group, * 1P < 0.01, * 2P < 0.05
Granulation tissue hyperplasia is tested: divide 5 groups at random by 50 mices, i.e. model group, positive controls, the present invention big or middle,
Small dose group, often group is 10, uses the burying storage modeling of cotton balls oxter.
Be administered: next day gastric infusion, continuous 7d, the large, medium and small dosage of the present invention；Positive controls is the same；Model group gavage
0.9% sodium chloride solution, volume is every 2ml, 30min after last is administered, and is put to death by animal, cotton balls granulation tissue is taken
Go out, dry in 60 DEG C of baking boxs and weigh.Deduct cotton balls quality with cotton balls granulation tissue dry weight, be granulation tissue net weight.
Mice oxter cotton balls is buried the impact (x ± s) of induction granulation tissue hyperplasia by table 2 present invention
Compare with negative control group, * 1P < 0.01, * 2P < 0.05
Experiment conclusion: the present invention big-and-middle dosed administration group can improve mice pain threshold and reduce acetic acid induced mice writhing time
Number, compares with negative control group, has significant difference (P < 0.05 or P < 0.01), show that the present invention has obvious analgesic activity.
Size dosed administration group can alleviate granulation tissue weight, cotton balls oxter is buried induction granulation tissue hyperplasia have significantly suppress make
With, compare with negative control group and have significant difference (P < 0.01, P < 0.05), show that the present invention has obvious antiinflammatory action.Combine
On, the present invention has certain therapeutical effect to rheumatic arthritis.
Claims (5)
1. Herba Cistanches health product, it is characterised in that its contained active component prepared by following raw materials in part by weight proportioning and
Become: Herba Cistanches 2 parts, Herba Lysimachiae hypercodis 50 parts, conyza blinii 60 parts, Herba asplenii trichomanis 55 parts, geranium 60 parts, wide leaf Largeleaf Gymnema
40 parts, cyrtomium caryotideumPresl 50 parts.
2. Herba Cistanches health product as claimed in claim 1, it is characterised in that preparation method step is: take above-mentioned in addition to Herba Cistanches
Other medical materials merge, boiling twice, collecting decoction, and when being concentrated into 65 DEG C, relative density is 1.10-1.20, add ethanol,
Stirring, makes alcohol content by volume percentage calculation reach 65-85%, stands, and filters, relative density during filtrate reduced in volume to 65 DEG C
For 1.20-1.30 and reclaim ethanol, being spray-dried by concentrated solution, gained granular powder is broken into dry extract, adds Herba Cistanches and auxiliary
Material, makes required preparation.
3. Herba Cistanches health product as claimed in claim 2, it is characterised in that in preparation method, decocting condition is: add water for the first time
Amount is the 8-12 times amount of medical material weight, decocts 1-2h, and amount of water is the 6-10 times amount of medical material weight for the second time, decocts 1-2h.
4. Herba Cistanches health product as claimed in claim 2, it is characterised in that in preparation method, spray drying condition is: air intake temperature
Degree is for 90-110 DEG C, and leaving air temp is 60-90 DEG C, and temperature of charge is 60-90 DEG C, and atomizing pressure is 0.2-0.5 MPa, spraying speed
Degree is 1-10ml/s.
5. Herba Cistanches health product application in anti-curing arthritis health product as claimed in claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610304500.3A CN105943633A (en) | 2016-05-10 | 2016-05-10 | Herba cistanches health care product and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610304500.3A CN105943633A (en) | 2016-05-10 | 2016-05-10 | Herba cistanches health care product and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105943633A true CN105943633A (en) | 2016-09-21 |
Family
ID=56914939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610304500.3A Withdrawn CN105943633A (en) | 2016-05-10 | 2016-05-10 | Herba cistanches health care product and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105943633A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108904520A (en) * | 2018-05-02 | 2018-11-30 | 广西医科大学 | Application of the wheat-based diet in terms of osteoarthritis drugs are treated in preparation |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1099983A (en) * | 1993-09-09 | 1995-03-15 | 袁双田 | Medicine for treating rheumatoid or rheumatic arthritis and hyperosteogeny, and method for preparing same |
| CN103735805A (en) * | 2014-01-22 | 2014-04-23 | 理想科技集团有限公司 | Health care product and preparation method thereof |
-
2016
- 2016-05-10 CN CN201610304500.3A patent/CN105943633A/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1099983A (en) * | 1993-09-09 | 1995-03-15 | 袁双田 | Medicine for treating rheumatoid or rheumatic arthritis and hyperosteogeny, and method for preparing same |
| CN103735805A (en) * | 2014-01-22 | 2014-04-23 | 理想科技集团有限公司 | Health care product and preparation method thereof |
Non-Patent Citations (6)
| Title |
|---|
| 《全国中草药汇编》编写组: "《全国中草药汇编》", 30 April 1978, 人民卫生出版社 * |
| 南京中医药大学编著: "《中药大辞典》", 31 March 2006, 上海科学技术出版社 * |
| 汪毅主编: "《精编中草药图谱：便携本》", 31 March 2013, 贵州科技出版社 * |
| 王绪前编著: "《方药传心录》", 28 February 2013, 中国中医药出版社 * |
| 秦莉花等: "中药内服外治膝骨性关节炎的研究概述", 《湖南中医药大学学报》 * |
| 郝近大主编: "《中华人民共和国药典辅助说明：2010版》", 30 June 2011, 中国中医药出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108904520A (en) * | 2018-05-02 | 2018-11-30 | 广西医科大学 | Application of the wheat-based diet in terms of osteoarthritis drugs are treated in preparation |
| CN108904520B (en) * | 2018-05-02 | 2021-10-12 | 广西医科大学 | Application of cistanche polysaccharide in preparation of osteoarthritis treatment medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102526318A (en) | Chinese medicinal composition for preventing and treating chicken diseases and preparation method thereof | |
| CN105169017A (en) | Traditional Chinese medicine for treating kidney stone and preparation method of traditional Chinese medicine | |
| CN104800759A (en) | Traditional Chinese medicine composition for treating rheumatic arthritis | |
| CN102727753B (en) | Traditional Chinese medicine composition used for treating gout, and preparation method and application thereof | |
| CN105753648A (en) | Method for extracting borneol from camphorwood branches and leaves | |
| CN111481638A (en) | Traditional Chinese medicine enema preparation for treating ulcerative colitis and preparation method thereof | |
| CN105943633A (en) | Herba cistanches health care product and application thereof | |
| CN1330359C (en) | Chinese medicine preparation for treating AIDS and process thereof | |
| CN103316252B (en) | A kind of Chinese medicine for the treatment of hepatic fibrosis | |
| CN103656323A (en) | Traditional Chinese medicine for treating erythroderma-type psoriasis | |
| CN104306784A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis as well as preparation method and application thereof | |
| CN105617160A (en) | Preparation method of traditional Chinese medicine for treating rheumatism and rheumatoid of middle-aged and elderly people | |
| CN103599328A (en) | Traditional Chinese medicine for treatment of pulmonary alveolar proteinosis | |
| CN103690715A (en) | Traditional Chinese medicine for treating ischemic colitis | |
| CN104208168B (en) | A kind of for compound traditional Chinese medicine composite treating poultry respiratory infection and preparation method thereof | |
| CN103735710A (en) | Traditional Chinese medicine composition for treating recessive mastitis of dairy cows and preparation method thereof | |
| CN103690709B (en) | A kind of Chinese medicine for the treatment of intestinal Behcet disease | |
| CN103055094B (en) | Traditional Chinese medicine for treating leukemia and preparation method thereof | |
| CN105663789A (en) | Traditional Chinese medicine composition for treating rheumatic arthritis as well as preparation method and application thereof | |
| CN105853843A (en) | Pharmaceutical composition for clinical pediatric wound care and preparation method of pharmaceutical composition for clinical pediatric wound care | |
| CN105079303A (en) | Medicine for preventing and curing Chicken infectious anemia | |
| CN105169342A (en) | Traditional Chinese medicine composition for treating eczema and preparation method thereof | |
| CN103599335A (en) | Traditional Chinese medicine for treatment of chronic colitis | |
| CN104825955A (en) | Medicine composition used for treating constipation of cattle and preparation method thereof | |
| CN103566226B (en) | Traditional Chinese medicament for treating suppurative pneumonia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160921 |